Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Results: Glenmark Pharmaceuticals posted a net profit of ₹348 crore in Q3 FY25, reversing a ₹351 crore loss YoY. Revenue ...

The short-term trend of Nifty remains positive, but the market is lacking the strength to surpass immediate hurdles. A ...

Keep up with the markets, earnings, and economy with high-quality news from 1,000s of journalists around the world.